Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-65.88	28.83	84.51
Graham Fair Price	26.20	2163.33	1714.20
PEG	-77.52	0.11	-0.50
Price/Book	36.07	0.48	0.35
Price/Cash Flow	inf	0.00	15.63
Prices/Earnings	-11.81	6.39	7.24
Price/Sales	7.71	2.17	2.02
Price/FCF	inf	0.00	15.63
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.72	0.24	0.24
Operating Margin	95.37	0.24	0.12
ROA	59.46	< 0.005	< 0.005
ROE	0.01	0.02	54.30
ROIC	< 0.005	0.02	205.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.07	0.02	256.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.34	1.50	342.59
EPS QOQ	-0.14	0.57	292.26
FCF QOQ	0.04	-1.00	2187.86
Revenue QOQ	-0.12	0.28	142.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	541.00	409.81	-24.25
Days Sales Outstanding (DSO)	19.51	13.42	-31.21
Inventory Turnover	0.17	0.22	32.01
Debt/Capitalization	0.61	0.59	-3.26
Quick Ratio	0.23	0.20	-12.94
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3282.28	3334.71	1.60
Cash	309.38	203.46	-34.24
Capex	0.00	0.00	0.00
Free Cash Flow	73.73	0.00	inf
Revenue	571.47	733.49	28.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.86	2.11	13.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	68.08	21.36	-68.63
Naive Interpretation	Member

06 - Financial Health · Bad

Rating